Graduate Seminar Series
Next full-series is scheduled to begin August 2019!
Have someone you think would make a great presenter? Let us know.
Calendar icon Tuesday, March 26, 2019
Assessing the Potential of Antimicrobial Blue Light and Combination Therapies to Treat and Prevent Infections Following Osseointegrated Implantation
Abstract: Antimicrobial blue light (aBL) has shown promise as a non-drug approach to combat microbial infections. aBL generally entails irradiation with visible light in the 400-470 µm wavelength range, and demonstrated to have broad spectrum antimicrobial properties. In this study, our collaborative group will take a phased and translational approach toward assessing the potential of antimicrobial blue light (aBL) therapy to treat and prevent OI implant-related infection with a focused approach against biofilms of Staphylococcus aureus.